c-Src regulates cell cycle proteins expression through protein kinase B/glycogen synthase kinase 3 beta and

Xiang Liu1, Liying Du, Renqing Feng

  • 1Department of Biochemistry and Molecular Biology, College of Life Sciences, Peking University, Beijing 100871, China.

Insights

c-Src suppression inhibits cell cycle progression in breast cancer by down-regulating cyclin D1/E and up-regulating p27 Kip1. This occurs via the AKT/GSK3β and ERK1/2 signaling pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • c-Src is implicated in epithelial to mesenchymal transition in breast cancer.
  • Understanding c-Src's role in cell cycle regulation is crucial for cancer therapy.

Purpose of the Study:

  • To investigate the role of c-Src in cell cycle progression.
  • To elucidate the signaling pathways involved in c-Src-mediated cell cycle regulation.

Main Methods:

  • Utilized small molecule inhibitor PP2 and siRNAs to suppress c-Src.
  • Performed Western blot analysis for cell cycle proteins (cyclin D1, cyclin E, p27 Kip1).
  • Assessed phosphorylation of key signaling molecules (ERK1/2, AKT, GSK3β) and used pathway-specific inhibitors.

Main Results:

  • c-Src suppression led to decreased cyclin D1/E and increased p27 Kip1 expression.
  • PP2 treatment inhibited phosphorylation of ERK1/2, AKT, and GSK3β.
  • Inhibition of AKT/GSK3β or ERK1/2 pathways mimicked the effects of c-Src suppression on cell cycle proteins.

Conclusions:

  • c-Src plays a significant role in regulating breast cancer cell cycle progression.
  • The AKT/GSK3β and ERK1/2 signaling pathways are critical mediators of c-Src's effects on cell cycle proteins.
  • Targeting c-Src may represent a viable therapeutic strategy for breast cancer.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...